Nature of change: Appointment of Senior Management Personnel
Name and DIN: Dr. Shubhadeep Sinha (DIN not disclosed in filing)
Effective date: 15th September 2026
Term of appointment: Duration of the contract shall be so long as he is in employment of the Company
Brief profile: Dr. Shubhadeep Sinha is a distinguished healthcare and pharmaceutical professional with over 25 years of experience in Clinical Development, Medical Affairs, Pharmacovigilance, Regulatory Affairs, and Healthcare Management
Relationship with other directors or promoters: Not Applicable (as per disclosure)
Regulatory compliance: Appointment disclosed pursuant to Regulation 30(2) of SEBI LODR Regulations, with additional details provided in Annexure I as required by Schedule III, Part A of SEBI LODR Regulations and SEBI Master Circular HO/49/14/14(7)2025CFDPOD2/I/3762/2026 dated January 30, 2026
Key Financial or Operational Approvals
No financial results, fundraising, or operational approvals mentioned in this disclosure
Strategic or Business Context
No strategic or business context, outlook commentary, or operational updates provided in this disclosure
Any Other Material Information
Filing details: Disclosure made to both BSE Limited (Scrip Code: 539523) and National Stock Exchange of India Limited (Scrip Symbol: ALKEM)
Company representative: Divya Kumar, Vice President – Legal & Deputy Company Secretary, signed and submitted the disclosure
Additional availability: The information is also available on the company website www.alkemlabs.com
